Dawnrays Pharmaceutical (Holdings) Limited

SEHK:2348 Stock Report

Mkt Cap: HK$2.0b

Dawnrays Pharmaceutical (Holdings) Management

How experienced are the management team and are they aligned to shareholders interests?

16.4yrs

Average management tenure


CEO

Weixian Wu (53 yo)

0.92yr

Tenure

Mr. Weixian Wu serves as Chief Executive Officer of Dawnrays Pharmaceutical (Holdings) Limited since February 16, 2022. He joined Nanjing PharmaRays Science and Technology Co., Ltd., a non-wholly owned sub...


Leadership Team

NamePositionTenureCompensationOwnership
Kei Ling Li
Co-Founder & Executive Chairman20.25yrsCN¥965.00k7.16%
CN¥ 143.9m
Yung Lai Hung
Co-Founder & Executive Director28yrsCN¥616.00k0.13%
CN¥ 2.5m
Weixian Wu
Chief Executive Officer0.92yrno datano data
Yi Jun Wu
Chief Financial Officer4.75yrsno datano data
Kit Ling Pang
Company Secretaryno datano datano data

16.4yrs

Average Tenure

58yo

Average Age

Experienced Management: 2348's management team is seasoned and experienced (16.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Kei Ling Li
Co-Founder & Executive Chairman20.25yrsCN¥965.00k7.16%
CN¥ 143.9m
Yung Lai Hung
Co-Founder & Executive Director20.25yrsCN¥616.00k0.13%
CN¥ 2.5m
Hao Xi Ede
Independent Non-Executive Director7.58yrsCN¥299.00kno data
Hong Man Leung
Non-Executive Director17.17yrsCN¥249.00kno data
Tung Sing Lo
Independent Non-Executive Director12.25yrsCN¥299.00kno data
Ming Yee Lam
Independent Non-Executive Director4.67yrsCN¥299.00kno data

14.7yrs

Average Tenure

58.5yo

Average Age

Experienced Board: 2348's board of directors are seasoned and experienced ( 14.7 years average tenure).